Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Pares

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Endocrine|October 22, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Endocrine|October 21, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitisKirsten Muri Boberg, Giuseppe Rocca, Thore Egeland, et al.
Clinical Reviews in Allergy & Immunology|September 11, 2014
Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centersAnnarosa Floreani, Alice Spinazzè, Llorenc Caballeria, et al.
Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Hepatology (Baltimore, Md.)|June 26, 2015
Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1Lucía Barbier-Torres, Naiara Beraza, Pablo Fernández-Tussy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre studyElisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trialRafael Bañares, Frederik Nevens, Fin Stolze Larsen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Endocrine|October 22, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Endocrine|October 21, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitisKirsten Muri Boberg, Giuseppe Rocca, Thore Egeland, et al.
Clinical Reviews in Allergy & Immunology|September 11, 2014
Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centersAnnarosa Floreani, Alice Spinazzè, Llorenc Caballeria, et al.
Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Hepatology (Baltimore, Md.)|June 26, 2015
Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1Lucía Barbier-Torres, Naiara Beraza, Pablo Fernández-Tussy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2017
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre studyElisabeth M G de Vries, Martti Färkkilä, Piotr Milkiewicz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trialRafael Bañares, Frederik Nevens, Fin Stolze Larsen, et al.
Pageof 4